Welcome to The CAPS Community!

This revolutionary service pools the resources of the Motley Fool Community to help you identify the best stocks at the best times to buy them -- and which stocks to avoid. Learn More or watch a quick intro video from David Gardner.

Be a smarter investor in just 3 steps...

  • Rate Stocks

    Test your picks against the best investors. Rate a stock!

  • Research Stocks

    Tap into community intelligence to find the best stocks. Find stock ideas!

  • Share Your Ideas

    Exchange thoughts with other active investors. Start blogging!

Recent Stock Pitches

  • Outperform
    Proto Labs, Inc. (PRLB)

    1 hour ago by foolwithfamily (58.15) | Reply

    This company focuses on helping customers manufacture things using the technology that makes sense, be it CNC machining, 3D printing or injection molding.I find that business model superior to "let's sell machine X", and the price has b... More

  • Underperform
    Viking Therapeutics (VKTX)

    2 hours ago by drugtrader (90.33) | Reply

    Delayed data. Try to get in near or even under $1 again. Hypercholesterolemia drug, while it may lower levels, is unlikely to show any overall improvement. But, its not phase 3 and it's also not the only. The hip fracture drug has incoming data a... More

  • Outperform
    Pronai Therapeutics (SRRA)

    2 hours ago by drugtrader (90.33) | Reply

    It's not really dead, its just pretending to be.

  • Outperform
    Zosano Pharma (ZSAN)

    2 hours ago by drugtrader (90.33) | Reply

    I really should have bought more when it was $1.40. It'll get bought out

  • Outperform
    Eiger BioPharmaceuticals, Inc. (EIGR)

    2 hours ago by drugtrader (90.33) | Reply

    Bought a few shares back after losing big when it was Celladon, and would definitely add in the single digits. High risk, high reward. Who says you can't time the market?

  • Underperform
    StemCells (MBOT)

    2 hours ago by drugtrader (90.33) | Reply

    We'll have gene editing and anti-aging rejuvenation before this comes close to being viable.

  • Outperform
    BP Prudhoe Bay Royalty Trust (BPT)

    2 hours ago by clangmead (62.95) | Reply

    lecsvnf

  • Outperform
    Onconova Therapeutics (ONTX)

    2 hours ago by drugtrader (90.33) | Reply

    I'm unfortunately long on this irl around my caps price. Not sure yet if I want to add but if I were to do so now is probably close to the right time.

  • Outperform
    Rxi Pharmaceuticals Corp (RXII)

    2 hours ago by drugtrader (90.33) | Reply

    Seems fairly safe for swing trading. Predictable movements in a tight range. Beware any news of delisting could be very negative for this highly shorted stock that really doesn't seem to have any good reason to go (and stay) over $1 in the very s... More

  • Outperform
    Tokai Pharmaceuticals (TKAI)

    2 hours ago by drugtrader (90.33) | Reply

    "Low risk" dumpster diving. Would be quick to sell any spike

  • Outperform
    Merrimack Pharmaceuticals (MACK)

    2 hours ago by drugtrader (90.33) | Reply

    Heard about an incoming dividend. Strange. Been following Merrimack since its IPO and overall I have positive sentiments for the company. I picked up a small position, but not for the dividend.

  • Outperform
    Argos Therapeutics (ARGS)

    3 hours ago by drugtrader (90.33) | Reply

    threw a green thumb too early. Total crap but looking to do a dumpster dive only if it drops by another half at least

  • Outperform
    Akebia Therapeutics (AKBA)

    3 hours ago by drugtrader (90.33) | Reply

    While I don't exactly hope this dips back to $8 or even 7, one would be foolish not to jump in big at that level considering it's a favorite of zzlangerhans and approved by Feurstein

  • Outperform
    Chiasma (CHMA)

    3 hours ago by drugtrader (90.33) | Reply

    Flatlining. Completely dead. Likely to go up 100%

  • Outperform
    Regulus Therapeutics (RGLS)

    3 hours ago by drugtrader (90.33) | Reply

    Couldn't hurt to have a few shares at this level. Risky, but big payoff especially with insider buy

  • Outperform
    Celldex Therapeutics, Inc. (CLDX)

    3 hours ago by drugtrader (90.33) | Reply

    Biotech with smart management, actually cares about shareholders. Likely to succeed eventually. Unrelated note, this was the first stock I ever bought when it was called Avant Therapeutics.

  • Underperform
    Netflix Inc (NFLX)

    3 hours ago by foolwithfamily (58.15) | Reply

    This is all story, because the numbers are all wrong. P/E, Forward P/E, EV/EBITDA, Shiller P/E are all three digit numbers, which I certainly don’t like in this weight class, and the cash is flowing out. Let’s be clear here: buying Netflix now is bet... More

  • Outperform
    Shopify (SHOP)

    9 hours ago by StockFrogger (< 20) | Reply

    Shopify is very "Amazon-like", providing a cloud-based e-commerce platform for small and medium-sized merchants. Since launching it's IPO in May 2015, the company has attracted attention more recently, growing its Quarterly EPS y-o-y by... More

  • Outperform
    Amazon.com, Inc. (AMZN)

    9 hours ago by StockFrogger (< 20) | Reply

    Over the past 10 years, AMZN has rewarded investors with a 34%/yr gain. What started out as an online book seller has morphed into three main businesses: a dominant online retailer, Amazon Web Services and venture capital. Based on its projected grow... More

  • Outperform
    Stemline Therapeutics (STML)

    9 hours ago by StockFrogger (< 20) | Reply

    Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology therapeutics. Stemline is developing three clinical stage product candidates, SL-401, SL-801, and SL-701 that target Cancer Stem Cells (CSC). Research... More

Top Fool

TMFBabo
  • TMFBabo
  • Rating: 100.00
  • Score: 56407.12

These kids are idiots. I've just traded all of Finland's boring stuff for every other country's

- Andy Dwyer ... More

Market Movers

Today's Best

Today's Worst

Most Pitches Today

AAPL $141.45 Up +0.53 (+0.38%)
Apple, Inc. CAPS Rating: 4 out of 5
AMZN $848.81 Up +1.43 (+0.17%)
Amazon.com, Inc. CAPS Rating: 4 out of 5
BIDU $169.38 Down -0.23 (-0.14%)
Baidu.com, Inc. (A... CAPS Rating: 5 out of 5
NFLX $142.33 Up +0.49 (+0.35%)
Netflix Inc CAPS Rating: 3 out of 5
JCP $5.47 Down -0.03 (-0.45%)
Penney J C Inc CAPS Rating: 1 out of 5

Featured Broker Partners